BJDX Logo

Bluejay Diagnostics, Inc. (BJDX) 

NASDAQ
Market Cap
$2.1M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
572 of 958
Rank in Industry
68 of 120

Largest Insider Buys in Sector

BJDX Stock Price History Chart

BJDX Stock Performance

About Bluejay Diagnostics, Inc.

Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a POC device for the …

Insider Activity of Bluejay Diagnostics, Inc.

Over the last 12 months, insiders at Bluejay Diagnostics, Inc. have bought $0 and sold $0 worth of Bluejay Diagnostics, Inc. stock.

On average, over the past 5 years, insiders at Bluejay Diagnostics, Inc. have bought $92,359 and sold $0 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 500 shares for transaction amount of $1,635 was made by Dey Indranil (President and CEO) on 2023‑12‑13.

List of Insider Buy and Sell Transactions, Bluejay Diagnostics, Inc.

2023-12-13PurchasePresident and CEO
500
0.044%
$3.27$1,635-85.64%
2023-12-13Purchasedirector
500
0.0413%
$3.07$1,535-85.64%
2023-03-28PurchasePresident and CEO
2,000
0.0105%
$0.44$880-49.65%
2023-03-27PurchasePresident and CEO
8,000
0.0393%
$0.44$3,520-53.01%
2023-03-24Purchasedirector
10,000
0.0502%
$0.44$4,400-51.67%
2022-08-26PurchaseChief Financial Officer
20,000
0.0992%
$1.03$20,600-57.23%
2022-04-25PurchaseChief Financial Officer
20,000
0.0943%
$0.99$19,800-21.74%
2022-03-17Purchase
40,000
0.1983%
$1.18$47,120-24.35%
2022-03-17PurchaseChief Financial Officer
2,500
0.0122%
$1.16$2,898-24.35%
2022-03-17Purchase
10,000
0.0498%
$1.18$11,830-24.35%
2022-03-16Purchase
60,000
0.2823%
$1.09$65,400-20.91%
2022-03-14PurchaseChief Financial Officer
5,000
0.0274%
$1.02$5,100+1.69%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.